{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:30Z","timestamp":1792783410979,"version":"4.5.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Department of Sichuan Province","award":["2025ZNSFSC1608"],"award-info":[{"award-number":["2025ZNSFSC1608"]}],"id":[{"id":"https:\/\/ror.org\/04323m874","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the West China Hospital \"Qimingxing\" Research Fund for Young Talents","award":["HXQMX0171"],"award-info":[{"award-number":["HXQMX0171"]}]},{"name":"the Sichuan Province Science and Technology Support Program","award":["2024YFFK0286"],"award-info":[{"award-number":["2024YFFK0286"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12012-026-10189-6","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:14:33Z","timestamp":1790759673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trained Immunity as a Mechanistic Bridge Between Uremic Toxins, Atherosclerosis, and Vascular Calcification in Chronic Kidney Disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Junyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"10189_CR1","doi-asserted-by":"publisher","first-page":"e240427","DOI":"10.1001\/jamanetworkopen.2024.0427","volume":"7","author":"JMT Colombijn","year":"2024","unstructured":"Colombijn, J. M. T., Idema, D. L., van Beem, S., Blokland, A. M., van der Braak, K., Handoko, M. L., In \u2019t Veld, L. F. H., Kaul, T., Kolagasigil-Akdemir, N., Kusters, M. P. T., Meijvis, S. C. A., Oosting, I. J., Spijker, R., Bots, M. L., Hooft, L., Verhaar, M. C., & Vernooij, R. W. M. (2024). Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic Review. JAMA Netw Open, 7, e240427. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.0427","journal-title":"JAMA Netw Open"},{"key":"10189_CR2","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","volume":"119","author":"C Zoccali","year":"2023","unstructured":"Zoccali, C., Mallamaci, F., Adamczak, M., de Oliveira, R. B., Massy, Z. A., Sarafidis, P., Agarwal, R., Mark, P. B., Kotanko, P., Ferro, C. J., Wanner, C., Burnier, M., Vanholder, R., & Wiecek, A. (2023). Cardiovascular complications in chronic kidney disease: A review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovascular Research, 119, 2017\u20132032. https:\/\/doi.org\/10.1093\/cvr\/cvad083","journal-title":"Cardiovascular Research"},{"key":"10189_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","volume":"91","author":"M Vervloet","year":"2017","unstructured":"Vervloet, M., & Cozzolino, M. (2017). Vascular calcification in chronic kidney disease: Different bricks in the wall? Kidney International, 91, 808\u2013817. https:\/\/doi.org\/10.1016\/j.kint.2016.09.024","journal-title":"Kidney International"},{"key":"10189_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13020142","volume":"13","author":"YJ Lim","year":"2021","unstructured":"Lim, Y. J., Sidor, N. A., Tonial, N. C., Che, A., Urquhart, B. L., Che, A., & Urquhart, B. L. (2021). Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: Mechanisms and therapeutic targets. Toxins, 13, Article 142. https:\/\/doi.org\/10.3390\/toxins13020142","journal-title":"Toxins"},{"key":"10189_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/tcmj.tcmj_293_24","volume":"37","author":"M-C Chen","year":"2025","unstructured":"Chen, M.-C., Kuo, C.-H., Lin, Y.-L., & Hsu, B.-G. (2025). Gut-derived uremic toxins and cardiovascular health in chronic kidney disease. Tzu Chi Medical Journal, 37, 264\u2013274. https:\/\/doi.org\/10.4103\/tcmj.tcmj_293_24","journal-title":"Tzu Chi Medical Journal"},{"key":"10189_CR6","doi-asserted-by":"publisher","unstructured":"Dom\u00ednguez-Andr\u00e9s, J., Dos Santos, J. C., Bekkering, S., Mulder, W. J. M., van der Meer, J. W. M., Riksen, N. P., Joosten, L. A. B., & Netea, M. G. (2023). Trained immunity: Adaptation within innate immune mechanisms. Physiological Reviews, 103, 313\u2013346. https:\/\/doi.org\/10.1152\/physrev.00031.2021","DOI":"10.1152\/physrev.00031.2021"},{"key":"10189_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCRESAHA.117.312465","volume":"122","author":"J Leentjens","year":"2018","unstructured":"Leentjens, J., Bekkering, S., Joosten, L. A. B., Netea, M. G., Burgner, D. P., & Riksen, N. P. (2018). Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis. Circ Res, 122, 664\u2013669. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312465","journal-title":"Circ Res"},{"key":"10189_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","volume":"172","author":"A Christ","year":"2018","unstructured":"Christ, A., G\u00fcnther, P., Lauterbach, M. A. R., Duewell, P., Biswas, D., Pelka, K., Scholz, C. J., Oosting, M., Haendler, K., Ba\u00dfler, K., Klee, K., Schulte-Schrepping, J., Ulas, T., Moorlag, S. J. C. F. M., Kumar, V., Park, M. H., Joosten, L. A. B., Groh, L. A., Riksen, N. P., \u2026 Latz, E. (2018). Western diet triggers NLRP3-dependent innate immune reprogramming. Cell, 172, 162-175.e14. https:\/\/doi.org\/10.1016\/j.cell.2017.12.013","journal-title":"Cell"},{"key":"10189_CR9","doi-asserted-by":"publisher","unstructured":"Groh, L. A., Ferreira, A. V., Helder, L., van der Heijden, C. D. C. C., Novakovic, B., van de Westerlo, E., Matzaraki, V., Moorlag, S. J. C. F. M., de Bree, L. C., Koeken, V. A. C. M., Mourits, V. P., Keating, S. T., van Puffelen, J. H., Hoischen, A., Joosten, L. A. B., Netea, M. G., Koopman, W. J. H., & Riksen, N. P. (2021). OxLDL-induced trained immunity is dependent on mitochondrial metabolic reprogramming. Immunometabolism, 3, Article e210025. https:\/\/doi.org\/10.20900\/immunometab20210025","DOI":"10.20900\/immunometab20210025"},{"key":"10189_CR10","doi-asserted-by":"publisher","unstructured":"Kim, H. Y., Kang, Y. J., Kim, D. H., Jang, J., Lee, S. J., Kim, G., Koh, H. B., Ko, Y. E., Shin, H. M., Lee, H., Yoo, T.-H., & Lee, W.-W. (2024). Uremic toxin indoxyl sulfate induces trained immunity via the AhR-dependent arachidonic acid pathway in end-stage renal disease (ESRD). eLife, 12, Article RP87316. https:\/\/doi.org\/10.7554\/eLife.87316","DOI":"10.7554\/eLife.87316"},{"key":"10189_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita, K., Ballew, S. H., Wang, A.-M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022). Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nature Reviews. Nephrology, 18, 696\u2013707. https:\/\/doi.org\/10.1038\/s41581-022-00616-6","journal-title":"Nature Reviews. Nephrology"},{"key":"10189_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.115.018713","volume":"133","author":"M Tonelli","year":"2016","unstructured":"Tonelli, M., Karumanchi, S. A., & Thadhani, R. (2016). Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation, 133, 518\u2013536. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018713","journal-title":"Circulation"},{"key":"10189_CR13","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., Coresh, J., & Gansevoort, R. T. (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: A collaborative meta-analysis of general population cohorts. Lancet, 375, 2073\u20132081. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5","journal-title":"Lancet"},{"key":"10189_CR14","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","volume":"46","author":"K Marx-Sch\u00fctt","year":"2025","unstructured":"Marx-Sch\u00fctt, K., Cherney, D. Z. I., Jankowski, J., Matsushita, K., Nardone, M., & Marx, N. (2025). Cardiovascular disease in chronic kidney disease. European Heart Journal, 46, 2148\u20132160. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf167","journal-title":"European Heart Journal"},{"key":"10189_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/toxins12060404","volume":"12","author":"I Six","year":"2020","unstructured":"Six, I., Flissi, N., Lenglet, G., Louvet, L., Kamel, S., Gallet, M., Massy, Z. A., & Liabeuf, S. (2020). Uremic toxins and vascular dysfunction. Toxins, 12, 404. https:\/\/doi.org\/10.3390\/toxins12060404","journal-title":"Toxins"},{"key":"10189_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCIMAGING.112.000165","volume":"6","author":"K Kato","year":"2013","unstructured":"Kato, K., Yonetsu, T., Jia, H., Abtahian, F., Vergallo, R., Hu, S., Tian, J., Kim, S. J., Lee, H., McNulty, I., Lee, S., Uemura, S., Jang, Y., Park, S. J., Mizuno, K., Yu, B., & Jang, I. K. (2013). Nonculprit coronary plaque characteristics of chronic kidney disease. Circulation: Cardiovascular Imaging, 6, 448\u2013456. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000165","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"10189_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.amjcard.2017.01.022","volume":"119","author":"CY Chin","year":"2017","unstructured":"Chin, C. Y., Matsumura, M., Maehara, A., Zhang, W., Lee, C. T., Yamamoto, M. H., Song, L., Parviz, Y., Jhalani, N. B., Mohan, S., Ratner, L. E., Cohen, D. J., Ben-Yehuda, O., Stone, G. W., Shlofmitz, R. A., Kakuta, T., Mintz, G. S., & Ali, Z. A. (2017). Coronary plaque characteristics in hemodialysis-dependent patients as assessed by optical coherence tomography. American Journal Of Cardiology, 119, 1313\u20131319. https:\/\/doi.org\/10.1016\/j.amjcard.2017.01.022","journal-title":"American Journal Of Cardiology"},{"key":"10189_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","volume":"15","author":"U Schwarz","year":"2000","unstructured":"Schwarz, U., Buzello, M., Ritz, E., Stein, G., Raabe, G., Wiest, G., Mall, G., & Amann, K. (2000). Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrology, Dialysis, Transplantation, 15, 218\u2013223. https:\/\/doi.org\/10.1093\/ndt\/15.2.218","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10189_CR19","doi-asserted-by":"publisher","first-page":"38869","DOI":"10.1074\/jbc.M110.166686","volume":"285","author":"S Ito","year":"2010","unstructured":"Ito, S., Osaka, M., Higuchi, Y., Nishijima, F., Ishii, H., & Yoshida, M. (2010). Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. Journal Of Biological Chemistry, 285, 38869\u201338875. https:\/\/doi.org\/10.1074\/jbc.M110.166686","journal-title":"Journal Of Biological Chemistry"},{"key":"10189_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.5551\/jat.34462","volume":"23","author":"S Ito","year":"2016","unstructured":"Ito, S., Osaka, M., Edamatsu, T., Itoh, Y., & Yoshida, M. (2016). Crucial role of the aryl hydrocarbon receptor (AhR) in indoxyl sulfate-induced vascular inflammation. Journal of Atherosclerosis and Thrombosis, 23, 960\u2013975. https:\/\/doi.org\/10.5551\/jat.34462","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"10189_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2215\/CJN.05340610","volume":"6","author":"M Yu","year":"2011","unstructured":"Yu, M., Kim, Y. J., & Kang, D.-H. (2011). Indoxyl sulfate\u2013induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clinical Journal of the American Society of Nephrology, 6, 30\u201339. https:\/\/doi.org\/10.2215\/CJN.05340610","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10189_CR22","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1681\/ASN.2010040365","volume":"21","author":"EO Apostolov","year":"2010","unstructured":"Apostolov, E. O., Ray, D., Savenka, A. V., Shah, S. V., & Basnakian, A. G. (2010). Chronic uremia stimulates LDL carbamylation and atherosclerosis. Journal Of The American Society Of Nephrology, 21, 1852\u20131857. https:\/\/doi.org\/10.1681\/ASN.2010040365","journal-title":"Journal Of The American Society Of Nephrology"},{"key":"10189_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/toxins16060254","volume":"16","author":"T Wakamatsu","year":"2024","unstructured":"Wakamatsu, T., Yamamoto, S., Yoshida, S., & Narita, I. (2024). Indoxyl sulfate-induced macrophage toxicity and therapeutic strategies in uremic atherosclerosis. Toxins, 16, Article 254. https:\/\/doi.org\/10.3390\/toxins16060254","journal-title":"Toxins"},{"key":"10189_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/biomedicines9040404","volume":"9","author":"P Dube","year":"2021","unstructured":"Dube, P., DeRiso, A., Patel, M., Battepati, D., Khatib-Shahidi, B., Sharma, H., Gupta, R., Malhotra, D., Dworkin, L., Haller, S., & Kennedy, D. (2021). Vascular calcification in chronic kidney disease: Diversity in the vessel wall. Biomedicines, 9, 404. https:\/\/doi.org\/10.3390\/biomedicines9040404","journal-title":"Biomedicines"},{"key":"10189_CR25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","volume":"91","author":"M Vervloet","year":"2017","unstructured":"Vervloet, M., & Cozzolino, M. (2017). Vascular calcification in chronic kidney disease: Different bricks in the wall? Kidney International, 91, 808\u2013817. https:\/\/doi.org\/10.1016\/j.kint.2016.09.024","journal-title":"Kidney International"},{"key":"10189_CR26","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00018-013-1554-3","volume":"71","author":"S Sinha","year":"2014","unstructured":"Sinha, S., Iyer, D., & Granata, A. (2014). Embryonic origins of human vascular smooth muscle cells: Implications for in vitro modeling and clinical application. Cellular And Molecular Life Sciences, 71, 2271\u20132288. https:\/\/doi.org\/10.1007\/s00018-013-1554-3","journal-title":"Cellular And Molecular Life Sciences"},{"key":"10189_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11040213","volume":"11","author":"M Cozzolino","year":"2019","unstructured":"Cozzolino, M., Ciceri, P., Galassi, A., Mangano, M., Carugo, S., Capelli, I., & Cianciolo, G. (2019). The key role of phosphate on vascular calcification. Toxins, 11, Article 213. https:\/\/doi.org\/10.3390\/toxins11040213","journal-title":"Toxins"},{"key":"10189_CR28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.123.065830","volume":"149","author":"X Zhai","year":"2024","unstructured":"Zhai, X., Cao, S., Wang, J., Qiao, B., Liu, X., Hua, R., Zhao, M., Sun, S., Han, Y., Wu, S., Pang, J., Yuan, Q., Wang, B., Xu, F., Wei, S., & Chen, Y. (2024). Carbonylation of Runx2 at K176 by 4-hydroxynonenal accelerates vascular calcification. Circulation, 149, 1752\u20131769. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065830","journal-title":"Circulation"},{"key":"10189_CR29","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1681\/ASN.2017050492","volume":"29","author":"J Voelkl","year":"2018","unstructured":"Voelkl, J., Tuffaha, R., Luong, T. T. D., Zickler, D., Masyout, J., Feger, M., Verheyen, N., Blaschke, F., Kuro-o, M., Tomaschitz, A., Pilz, S., Pasch, A., Eckardt, K.-U., Scherberich, J. E., Lang, F., Pieske, B., & Alesutan, I. (2018). Zinc inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-\u03baB. Journal of the American Society of Nephrology\u202f: JASN, 29, 1636\u20131648. https:\/\/doi.org\/10.1681\/ASN.2017050492","journal-title":"Journal of the American Society of Nephrology : JASN"},{"key":"10189_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCRESAHA.123.323365","volume":"134","author":"M Faleeva","year":"2024","unstructured":"Faleeva, M., Ahmad, S., Theofilatos, K., Lynham, S., Watson, G., Whitehead, M., Marhuenda, E., Iskratsch, T., Cox, S., & Shanahan, C. M. (2024). Sox9 accelerates vascular aging by regulating extracellular matrix composition and stiffness. Circ Res, 134, 307\u2013324. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323365","journal-title":"Circ Res"},{"key":"10189_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/biomedicines9040404","volume":"9","author":"P Dube","year":"2021","unstructured":"Dube, P., DeRiso, A., Patel, M., Battepati, D., Khatib-Shahidi, B., Sharma, H., Gupta, R., Malhotra, D., Dworkin, L., Haller, S., & Kennedy, D. (2021). Vascular calcification in chronic kidney disease: Diversity in the vessel wall. Biomedicines, 9, 404. https:\/\/doi.org\/10.3390\/biomedicines9040404","journal-title":"Biomedicines"},{"key":"10189_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41569-023-00894-y","volume":"20","author":"NP Riksen","year":"2023","unstructured":"Riksen, N. P., Bekkering, S., Mulder, W. J. M., & Netea, M. G. (2023). Trained immunity in atherosclerotic cardiovascular disease. Nature Reviews Cardiology, 20, 799\u2013811. https:\/\/doi.org\/10.1038\/s41569-023-00894-y","journal-title":"Nature Reviews Cardiology"},{"key":"10189_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","volume":"19","author":"J Ochando","year":"2023","unstructured":"Ochando, J., Mulder, W. J. M., Madsen, J. C., Netea, M. G., & Duivenvoorden, R. (2023). Trained immunity - basic concepts and contributions to immunopathology. Nature Reviews Nephrology, 19, 23\u201337. https:\/\/doi.org\/10.1038\/s41581-022-00633-5","journal-title":"Nature Reviews Nephrology"},{"key":"10189_CR34","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder, R., Smet, R. D., Glorieux, G., Argil\u00e9s, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., Deyn, P. P. D., Deppisch, R., Descamps-Latscha, B., Henle, T., J\u00f6rres, A., Lemke, H. D., Massy, Z. A., Passlick-Deetjen, J., Rodriguez, M., Stegmayr, B., Stenvinkel, P., Tetta, C., & Wanner, C. (2003). .T.W. Group (EUTox), Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney International, 63, 1934\u20131943. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00924.x. Zidek, F. the E.U.","journal-title":"Kidney International"},{"key":"10189_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2741\/4595","volume":"23","author":"Y Sun","year":"2018","unstructured":"Sun, Y., Johnson, C., Zhou, J., Wang, L., Li, Y. F., Lu, Y., Nanayakkara, G., Fu, H., Shao, Y., Sanchez, C., Yang, W. Y., Wang, X., Choi, E. T., Li, R., Wang, H., & Yang, X. F. (2018). Uremic toxins are conditional danger- or homeostasis-associated molecular patterns. Front Biosci (Landmark Ed), 23, 348\u2013387. https:\/\/doi.org\/10.2741\/4595","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10189_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87316","volume":"12","author":"HY Kim","year":"2024","unstructured":"Kim, H. Y., Kang, Y. J., Kim, D. H., Jang, J., Lee, S. J., Kim, G., Koh, H. B., Ko, Y. E., Shin, H. M., Lee, H., Yoo, T.-H., & Lee, W.-W. (2024). Uremic toxin indoxyl sulfate induces trained immunity via the AhR-dependent arachidonic acid pathway in end-stage renal disease (ESRD). eLife, 12, Article RP87316. https:\/\/doi.org\/10.7554\/eLife.87316","journal-title":"eLife"},{"key":"10189_CR37","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.3390\/toxins7083155","volume":"7","author":"K Matsuo","year":"2015","unstructured":"Matsuo, K., Yamamoto, S., Wakamatsu, T., Takahashi, Y., Kawamura, K., Kaneko, Y., Goto, S., Kazama, J. J., & Narita, I. (2015). Increased proinflammatory cytokine production and decreased cholesterol efflux due to downregulation of ABCG1 in macrophages exposed to indoxyl sulfate. Toxins, 7, 3155\u20133166. https:\/\/doi.org\/10.3390\/toxins7083155","journal-title":"Toxins"},{"key":"10189_CR38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"C-Y Sun","year":"2012","unstructured":"Sun, C.-Y., Chang, S.-C., & Wu, M.-S. (2012). Suppression of klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney International, 81, 640\u2013650. https:\/\/doi.org\/10.1038\/ki.2011.445","journal-title":"Kidney International"},{"key":"10189_CR39","doi-asserted-by":"publisher","first-page":"77722","DOI":"10.18632\/oncotarget.20773","volume":"8","author":"CY Sun","year":"2017","unstructured":"Sun, C. Y., Cheng, M. L., Pan, H. C., Lee, J. H., & Lee, C. C. (2017). Protein-bound uremic toxins impaired mitochondrial dynamics and functions. Oncotarget, 8, 77722\u201377733. https:\/\/doi.org\/10.18632\/oncotarget.20773","journal-title":"Oncotarget"},{"key":"10189_CR40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ki.2015.287","volume":"89","author":"YJ Jing","year":"2016","unstructured":"Jing, Y. J., Ni, J. W., Ding, F. H., Fang, Y. H., Wang, X. Q., Wang, H. B., Chen, X. N., Chen, N., Zhan, W. W., Lu, L., & Zhang, R. Y. (2016). P-cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE\u2212\/\u2212 mice. Kidney International, 89, 439\u2013449. https:\/\/doi.org\/10.1038\/ki.2015.287","journal-title":"Kidney International"},{"key":"10189_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110521","volume":"301","author":"JH Han","year":"2025","unstructured":"Han, J. H., Rey, F. E., & Denu, J. M. (2025). Gut microbiota\u2013derived metabolite trimethylamine N-oxide alters the host epigenome through inhibition of S-adenosylhomocysteine hydrolase. Journal of Biological Chemistry, 301, Article 110521. https:\/\/doi.org\/10.1016\/j.jbc.2025.110521","journal-title":"Journal of Biological Chemistry"},{"key":"10189_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.158183","volume":"8","author":"F Saaoud","year":"2023","unstructured":"Saaoud, F., Liu, L., Xu, K., Cueto, R., Shao, Y., Lu, Y., Sun, Y., Snyder, N. W., Wu, S., Yang, L., Zhou, Y., Williams, D. L., Li, C., Martinez, L., Vazquez-Padron, R. I., Zhao, H., Jiang, X., Wang, H., & Yang, X. (2023). Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress\/mitochondrial ROS\/glycolysis pathways. JCI Insight, 8, Article e158183. https:\/\/doi.org\/10.1172\/jci.insight.158183","journal-title":"JCI Insight"},{"key":"10189_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110878","volume":"514","author":"X Han","year":"2020","unstructured":"Han, X., Ma, W., Zhu, Y., Sun, X., & Liu, N. (2020). Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1\u03b1\/PDK4 pathway. Molecular and Cellular Endocrinology, 514, Article 110878. https:\/\/doi.org\/10.1016\/j.mce.2020.110878","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10189_CR44","doi-asserted-by":"publisher","first-page":"ATu0039","DOI":"10.1161\/atv.45.suppl_1.Tu0039","volume":"45","author":"V Kumar","year":"2025","unstructured":"Kumar, V., Nimma, R., Yepuri, G., Uribe Echevarria Zubizarreta, V., Ramasamy, R., & Schmidt, A. M. (2025). Abstract Tu0039: Ligands of the receptor for advanced glycation end products (RAGE) induce trained immunity in mouse bone marrow-derived macrophages (BMDMs). Arteriosclerosis, Thrombosis, and Vascular Biology, 45, ATu0039\u2013ATu0039. https:\/\/doi.org\/10.1161\/atv.45.suppl_1.Tu0039","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10189_CR45","doi-asserted-by":"publisher","first-page":"732450","DOI":"10.1155\/2015\/732450","volume":"2015","author":"X Jin","year":"2015","unstructured":"Jin, X., Yao, T., Zhou, Z., Zhu, J., Zhang, S., Hu, W., & Shen, C. (2015). Advanced glycation end products enhance macrophages polarization into M1 phenotype through activating RAGE\/NF-\u03baB pathway. Biomed Research International, 2015, 732450. https:\/\/doi.org\/10.1155\/2015\/732450","journal-title":"Biomed Research International"},{"key":"10189_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/ATVBAHA.120.314212","volume":"41","author":"H Tercan","year":"2021","unstructured":"Tercan, H., Riksen, N. P., Joosten, L. A. B., Netea, M. G., & Bekkering, S. (2021). Trained immunity. Arteriosclerosis Thrombosis and Vascular Biology, 41, 55\u201361. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314212","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"key":"10189_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02580-1","volume":"23","author":"M Badii","year":"2021","unstructured":"Badii, M., Gaal, O. I., Cleophas, M. C., Kl\u00fcck, V., Davar, R., Habibi, E., Keating, S. T., Novakovic, B., Helsen, M. M., Dalbeth, N., Stamp, L. K., Macartney-Coxson, D., Phipps-Green, A. J., Stunnenberg, H. G., Dinarello, C. A., Merriman, T. R., Netea, M. G., Cri\u015fan, T. O., & Joosten, L. A. B. (2021). Urate-induced epigenetic modifications in myeloid cells. Arthritis Research & Therapy, 23, Article 202. https:\/\/doi.org\/10.1186\/s13075-021-02580-1","journal-title":"Arthritis Research & Therapy"},{"key":"10189_CR48","doi-asserted-by":"publisher","first-page":"1007103","DOI":"10.37349\/emd.2025.1007103","volume":"3","author":"OI Gaal","year":"2025","unstructured":"Gaal, O. I., Joosten, L. A. B., & Cri\u0219an, T. O. (2025). Targeting innate immune memory: A new paradigm for gout treatment. Explor Musculoskeletal Dis, 3, 1007103. https:\/\/doi.org\/10.37349\/emd.2025.1007103","journal-title":"Explor Musculoskeletal Dis"},{"key":"10189_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/imr.12833","volume":"294","author":"G Cab\u0103u","year":"2020","unstructured":"Cab\u0103u, G., Cri\u0219an, T. O., Kl\u00fcck, V., Popp, R. A., & Joosten, L. A. B. (2020). Urate-induced immune programming: Consequences for gouty arthritis and hyperuricemia. Immunological Reviews, 294, 92\u2013105. https:\/\/doi.org\/10.1111\/imr.12833","journal-title":"Immunological Reviews"},{"key":"10189_CR50","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Cri\u0219an","year":"2016","unstructured":"Cri\u0219an, T. O., Cleophas, M. C. P., Oosting, M., Lemmers, H., Toenhake-Dijkstra, H., Netea, M. G., Jansen, T. L., & Joosten, L. A. B. (2016). Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Annals of the Rheumatic Diseases, 75, 755\u2013762. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206564","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10189_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/ATVBAHA.114.303817","volume":"35","author":"Y Xiao","year":"2015","unstructured":"Xiao, Y., Huang, W., Zhang, J., Peng, C., Xia, M., & Ling, W. (2015). Increased plasma S-adenosylhomocysteine\u2013accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE\u2212\/\u2212 mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 60\u201370. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303817","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10189_CR52","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3724\/abbs.2025021","volume":"56","author":"Q Liu","year":"2025","unstructured":"Liu, Q., Li, F., Hu, S., Ding, N., Ma, F., Hao, Y., Li, G., Xiong, J., Zhang, H., & Jiang, Y. (2025). Pyruvate dehydrogenase alleviates macrophage autophagy in hcy-induced ApoE \u2013\/\u2013 mice. Acta Biochimica et Biophysica Sinica (Shanghai), 56, 2022\u20132033. https:\/\/doi.org\/10.3724\/abbs.2025021","journal-title":"Acta Biochimica et Biophysica Sinica (Shanghai)"},{"key":"10189_CR53","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.3390\/ijms160612560","volume":"16","author":"JJ Li","year":"2015","unstructured":"Li, J. J., Li, Q., Du, H. P., Wang, Y. L., You, S. J., Wang, F., Xu, X. S., Cheng, J., Cao, Y. J., Liu, C. F., & Hu, L. F. (2015). Homocysteine triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter. International Journal Of Molecular Sciences, 16, 12560\u201312577. https:\/\/doi.org\/10.3390\/ijms160612560","journal-title":"International Journal Of Molecular Sciences"},{"key":"10189_CR54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/0886022X.2022.2036620","volume":"44","author":"M Wang","year":"2022","unstructured":"Wang, M., Lin, X., Yang, X., & Yang, Y. (2022). Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease. Renal Failure, 44, 615\u2013624. https:\/\/doi.org\/10.1080\/0886022X.2022.2036620","journal-title":"Renal Failure"},{"key":"10189_CR55","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2215\/CJN.10110917","volume":"13","author":"M Wolley","year":"2018","unstructured":"Wolley, M., Jardine, M., & Hutchison, C. A. (2018). Exploring the clinical relevance of providing increased removal of large middle molecules. Clinical Journal Of The American Society Of Nephrology, 13, 805\u2013814. https:\/\/doi.org\/10.2215\/CJN.10110917","journal-title":"Clinical Journal Of The American Society Of Nephrology"},{"key":"10189_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13040246","volume":"13","author":"S Magnani","year":"2021","unstructured":"Magnani, S., & Atti, M. (2021). Uremic toxins and blood purification: A review of current evidence and future perspectives. Toxins, 13, Article 246. https:\/\/doi.org\/10.3390\/toxins13040246","journal-title":"Toxins"},{"issue":"1","key":"10189_CR57","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1038\/s41598-017-03130-z","volume":"7","author":"HY Kim","year":"2017","unstructured":"Kim, H. Y., Yoo, T.-H., Hwang, Y., Lee, G. H., Kim, B., Jang, J., Yu, H. T., Kim, M. C., Cho, J.-Y., Lee, C. J., Kim, H. C., Park, S., & Lee, W.-W. (2017). Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). Scientific Reports, 7, 3057. https:\/\/doi.org\/10.1038\/s41598-017-03130-z","journal-title":"Scientific Reports"},{"key":"10189_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8120358","volume":"8","author":"SC Leong","year":"2016","unstructured":"Leong, S. C., & Sirich, T. L. (2016). Indoxyl sulfate\u2014review of toxicity and therapeutic strategies. Toxins, 8, Article 358. https:\/\/doi.org\/10.3390\/toxins8120358","journal-title":"Toxins"},{"key":"10189_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF03226377","volume":"26","author":"E Banoglu","year":"2001","unstructured":"Banoglu, E., Jha, G. G., & King, R. S. (2001). Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate. European Journal of Drug Metabolism and Pharmacokinetics, 26, 235\u2013240. https:\/\/doi.org\/10.1007\/BF03226377","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10189_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF03190428","volume":"27","author":"E Banoglu","year":"2002","unstructured":"Banoglu, E., & King, R. S. (2002). Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate. European Journal of Drug Metabolism and Pharmacokinetics, 27, 135\u2013140. https:\/\/doi.org\/10.1007\/BF03190428","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10189_CR61","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/toxins6020416","volume":"6","author":"E Devine","year":"2014","unstructured":"Devine, E., Krieter, D. H., R\u00fcth, M., Jankovski, J., & Lemke, H.-D. (2014). Binding affinity and capacity for the uremic toxin indoxyl sulfate. Toxins, 6, 416\u2013429. https:\/\/doi.org\/10.3390\/toxins6020416","journal-title":"Toxins"},{"key":"10189_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","volume":"139","author":"T Nakano","year":"2019","unstructured":"Nakano, T., Katsuki, S., Chen, M., Decano, J. L., Halu, A., Lee, L. H., Pestana, D. V. S., Kum, A. S. T., Kuromoto, R. K., Golden, W. S., Boff, M. S., Guimaraes, G. C., Higashi, H., Kauffman, K. J., Maejima, T., Suzuki, T., Iwata, H., Barab\u00e1si, A. L., Aster, J. C., Anderson, D. G., Sharma, A., Singh, S. A., Aikawa, E., & Aikawa, M. (2019). Uremic toxin indoxyl sulfate promotes pro-inflammatory macrophage activation via the interplay of OATP2B1 and Dll4-notch signaling. Circulation, 139, 78\u201396. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034588","journal-title":"Circulation"},{"key":"10189_CR63","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/bi901786x","volume":"49","author":"JC Schroeder","year":"2010","unstructured":"Schroeder, J. C., DiNatale, B. C., Murray, I. A., Flaveny, C. A., Liu, Q., Laurenzana, E. M., Lin, J. M., Strom, S. C., Omiecinski, C. J., Amin, S., & Perdew, G. H. (2010). The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry, 49, 393\u2013400. https:\/\/doi.org\/10.1021\/bi901786x","journal-title":"Biochemistry"},{"key":"10189_CR64","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-019-2054-5","volume":"17","author":"H Zhao","year":"2019","unstructured":"Zhao, H., Chen, L., Yang, T., Feng, Y. L., Vaziri, N. D., Liu, B. L., Liu, Q. Q., Guo, Y., & Zhao, Y. Y. (2019). Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma. J Transl Med, 17, 302. https:\/\/doi.org\/10.1186\/s12967-019-2054-5","journal-title":"J Transl Med"},{"key":"10189_CR65","doi-asserted-by":"publisher","first-page":"30619","DOI":"10.1073\/pnas.2002732117","volume":"117","author":"ACG Salina","year":"2020","unstructured":"Salina, A. C. G., Brandt, S. L., Klopfenstein, N., Blackman, A., Bazzano, J. M. R., S\u00e1-Nunes, A., Byers-Glosson, N., Brodskyn, C., Tavares, N. M., Da Silva, I. B. S., Medeiros, A. I., & Serezani, C. H. (2020). Leukotriene B4 licenses inflammasome activation to enhance skin host defense. Proceedings of the National Academy of Sciences of the United States of America, 117, 30619\u201330627. https:\/\/doi.org\/10.1073\/pnas.2002732117","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10189_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/toxins9020052","volume":"9","author":"T Gryp","year":"2017","unstructured":"Gryp, T., Vanholder, R., Vaneechoutte, M., & Glorieux, G. (2017). p-cresyl sulfate. Toxins (Basel), 9, 52. https:\/\/doi.org\/10.3390\/toxins9020052","journal-title":"Toxins (Basel)"},{"key":"10189_CR67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","volume":"90","author":"N Gamage","year":"2006","unstructured":"Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006). Human sulfotransferases and their role in chemical metabolism. Toxicological Sciences, 90, 5\u201322. https:\/\/doi.org\/10.1093\/toxsci\/kfj061","journal-title":"Toxicological Sciences"},{"key":"10189_CR68","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1681\/ASN.2005030310","volume":"16","author":"AW Martinez","year":"2005","unstructured":"Martinez, A. W., Recht, N. S., Hostetter, T. H., & Meyer, T. W. (2005). Removal of P-cresol sulfate by hemodialysis. Journal of the American Society of Nephrology, 16, 3430\u20133436. https:\/\/doi.org\/10.1681\/ASN.2005030310","journal-title":"Journal of the American Society of Nephrology"},{"key":"10189_CR69","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ndt\/gfl584","volume":"22","author":"E Schepers","year":"2007","unstructured":"Schepers, E., Meert, N., Glorieux, G., Goeman, J., Van der Eycken, J., & Vanholder, R. (2007). P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrology, Dialysis, Transplantation, 22, 592\u2013596. https:\/\/doi.org\/10.1093\/ndt\/gfl584","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10189_CR70","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","volume":"83","author":"H Watanabe","year":"2013","unstructured":"Watanabe, H., Miyamoto, Y., Honda, D., Tanaka, H., Wu, Q., Endo, M., Noguchi, T., Kadowaki, D., Ishima, Y., Kotani, S., Nakajima, M., Kataoka, K., Kim-Mitsuyama, S., Tanaka, M., Fukagawa, M., Otagiri, M., & Maruyama, T. (2013). p-cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney International, 83, 582\u2013592. https:\/\/doi.org\/10.1038\/ki.2012.448","journal-title":"Kidney International"},{"key":"10189_CR71","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature, 464, 104\u2013107. https:\/\/doi.org\/10.1038\/nature08780","journal-title":"Nature"},{"key":"10189_CR72","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","volume":"24","author":"RJW Arts","year":"2016","unstructured":"Arts, R. J. W., Novakovic, B., ter Horst, R., Carvalho, A., Bekkering, S., Lachmandas, E., Rodrigues, F., Silvestre, R., Cheng, S. C., Wang, S. Y., Habibi, E., Gon\u00e7alves, L. G., Mesquita, I., Cunha, C., van Laarhoven, A., van de Veerdonk, F. L., Williams, D. L., van der Meer, J. W. M., Logie, C., O\u2019Neill, L. A., Dinarello, C. A., Riksen, N. P., van Crevel, R., Clish, C., Notebaart, R. A., Joosten, L. A. B., Stunnenberg, H. G., Xavier, R. J., & Netea, M. G. (2016). Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab, 24, 807\u2013819. https:\/\/doi.org\/10.1016\/j.cmet.2016.10.008","journal-title":"Cell Metab"},{"key":"10189_CR73","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3389\/fimmu.2020.01715","volume":"11","author":"CA P\u00e9rez-Hern\u00e1ndez","year":"2020","unstructured":"P\u00e9rez-Hern\u00e1ndez, C. A., Kern, C. C., Butkeviciute, E., McCarthy, E., Dockrell, H. M., Moreno-Altamirano, M. M. B., Aguilar-L\u00f3pez, B. A., Bhosale, G., Wang, H., Gems, D., Duchen, M. R., & Smith, S. G. (2020). S\u00e1nchez-Garc\u00eda, Mitochondrial signature in human monocytes and resistance to infection in C. elegans during fumarate-induced innate immune training. Frontiers In Immunology, 11, 1715. https:\/\/doi.org\/10.3389\/fimmu.2020.01715","journal-title":"Frontiers In Immunology"},{"key":"10189_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13020142","volume":"13","author":"YJ Lim","year":"2021","unstructured":"Lim, Y. J., Sidor, N. A., Tonial, N. C., Che, A., & Urquhart, B. L. (2021). Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: Mechanisms and therapeutic targets. Toxins (Basel), 13, Article 142. https:\/\/doi.org\/10.3390\/toxins13020142","journal-title":"Toxins (Basel)"},{"key":"10189_CR75","doi-asserted-by":"publisher","first-page":"21307","DOI":"10.1073\/pnas.1215689109","volume":"109","author":"S Craciun","year":"2012","unstructured":"Craciun, S., & Balskus, E. P. (2012). Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci U S A, 109, 21307\u201321312. https:\/\/doi.org\/10.1073\/pnas.1215689109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10189_CR76","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","volume":"20","author":"RA Koeth","year":"2014","unstructured":"Koeth, R. A., Levison, B. S., Culley, M. K., Buffa, J. A., Wang, Z., Gregory, J. C., Org, E., Wu, Y., Li, L., Smith, J. D., Wilson Tang, W. H., DiDonato, J. A., & Lusis, A. J. (2014). Hazen, \u03b3\u2013butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab, 20, 799\u2013812. https:\/\/doi.org\/10.1016\/j.cmet.2014.10.006","journal-title":"Cell Metab"},{"key":"10189_CR77","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.pharmthera.2005.01.001","volume":"106","author":"SK Krueger","year":"2005","unstructured":"Krueger, S. K., & Williams, D. E. (2005). Mammalian flavin-containing monooxygenases: Structure\/function, genetic polymorphisms and role in drug metabolism. Pharmacology & Therapeutics, 106, 357\u2013387. https:\/\/doi.org\/10.1016\/j.pharmthera.2005.01.001","journal-title":"Pharmacology & Therapeutics"},{"key":"10189_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143731","volume":"10","author":"X Hai","year":"2015","unstructured":"Hai, X., Landeras, V., Dobre, M. A., DeOreo, P., Meyer, T. W., & Hostetter, T. H. (2015). Mechanism of prominent trimethylamine oxide (TMAO) accumulation in hemodialysis patients. PLoS One, 10, Article e0143731. https:\/\/doi.org\/10.1371\/journal.pone.0143731","journal-title":"PLoS One"},{"key":"10189_CR79","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.cmet.2019.08.021","volume":"30","author":"S Chen","year":"2019","unstructured":"Chen, S., Henderson, A., Petriello, M. C., Romano, K. A., Gearing, M., Miao, J., Schell, M., Sandoval-Espinola, W. J., Tao, J., Sha, B., Graham, M., Crooke, R., Kleinridders, A., Balskus, E. P., Rey, F. E., Morris, A. J., & Biddinger, S. B. (2019). Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction. Cell Metabolism, 30, 1141-1151e.e5. https:\/\/doi.org\/10.1016\/j.cmet.2019.08.021","journal-title":"Cell Metabolism"},{"key":"10189_CR80","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006347","volume":"6","author":"M Chen","year":"2017","unstructured":"Chen, M., Zhu, X., Ran, L., Lang, H., Yi, L., & Mi, M. (2017). Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. Journal of the American Heart Association, 6, Article e006347. https:\/\/doi.org\/10.1161\/JAHA.117.006347","journal-title":"Journal of the American Heart Association"},{"key":"10189_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67457-w","volume":"10","author":"S Noh","year":"2020","unstructured":"Noh, S., Phorl, S., Naskar, R., Oeum, K., Seo, Y., Kim, E., Kweon, H.-S., & Lee, J.-Y. (2020). p32\/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis. Scientific Reports, 10, Article 10618. https:\/\/doi.org\/10.1038\/s41598-020-67457-w","journal-title":"Scientific Reports"},{"key":"10189_CR82","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., Manjeri, G. R., Li, Y., Ifrim, D. C., Arts, R. J. W., van der Meer, B. M. J. W., Deen, P. M. T., Logie, C., O\u2019Neill, L. A., Willems, P., van de Veerdonk, F. L., van der Meer, J. W. M., Ng, A., Joosten, L. A. B., Wijmenga, C., Stunnenberg, H. G., Xavier, R. J., & Netea, M. G. (2014). mTOR\/HIF1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science, 345, 1250684. https:\/\/doi.org\/10.1126\/science.1250684","journal-title":"Science"},{"key":"10189_CR83","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009). ATP-citrate lyase links cellular metabolism to histone acetylation. Science, 324, 1076\u20131080. https:\/\/doi.org\/10.1126\/science.1164097","journal-title":"Science"},{"key":"10189_CR84","first-page":"66","volume":"154","author":"LC","year":"1912","unstructured":"LC. (1912). Action of amino acids on sugars. Formation of melanoidins in a methodical way. Compte-Rendu de l\u2019Academie Des Sciences, 154, 66\u201368.","journal-title":"Compte-Rendu de l\u2019Academie Des Sciences"},{"key":"10189_CR85","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1523-1755.1999.00302.x","volume":"55","author":"T Miyata","year":"1999","unstructured":"Miyata, T., van Ypersele de Strihou, C., Kurokawa, K., & Baynes, J. W. (1999). Alterations in nonenzymatic biochemistry in uremia: Origin and significance of \u201ccarbonyl stress\u201d in long-term uremic complications. Kidney International, 55, 389\u2013399. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00302.x","journal-title":"Kidney International"},{"key":"10189_CR86","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1681\/ASN.2014101047","volume":"27","author":"AEM Stinghen","year":"2016","unstructured":"Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E., & Boullier, A. (2016). Uremic toxicity of advanced glycation end products in CKD. Journal Of The American Society Of Nephrology, 27, 354\u2013370. https:\/\/doi.org\/10.1681\/ASN.2014101047","journal-title":"Journal Of The American Society Of Nephrology"},{"key":"10189_CR87","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki, A., & Medzhitov, R. (2015). Control of adaptive immunity by the innate immune system. Nature Immunology, 16, 343\u2013353. https:\/\/doi.org\/10.1038\/ni.3123","journal-title":"Nature Immunology"},{"key":"10189_CR88","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","volume":"280","author":"MP Wautier","year":"2001","unstructured":"Wautier, M. P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. L. (2001). Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. American Journal of Physiology, Endocrinology and Metabolism, 280, E685-694. https:\/\/doi.org\/10.1152\/ajpendo.2001.280.5.E685","journal-title":"American Journal of Physiology, Endocrinology and Metabolism"},{"key":"10189_CR89","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.cell.2004.08.025","volume":"118","author":"D Gerald","year":"2004","unstructured":"Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouyss\u00e9gur, J., & Yaniv, M. (2004). Mechta-Grigoriou, JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell, 118, 781\u2013794. https:\/\/doi.org\/10.1016\/j.cell.2004.08.025","journal-title":"Cell"},{"key":"10189_CR90","doi-asserted-by":"publisher","unstructured":"Quintin, J., Saeed, S., Martens, J. H. A., Giamarellos-Bourboulis, E. J., Ifrim, D. C., Logie, C., Jacobs, L., Jansen, T., Kullberg, B. J., Wijmenga, C., Joosten, L. A. B., Xavier, R. J., van der Meer, J. W. M., Stunnenberg, H. G., & Netea, M. G. (2012). Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host & Microbe, 12. https:\/\/doi.org\/10.1016\/j.chom.2012.06.006","DOI":"10.1016\/j.chom.2012.06.006"},{"key":"10189_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102828","volume":"65","author":"Y You","year":"2023","unstructured":"You, Y., Chen, X., Chen, Y., Pang, J., Chen, Q., Liu, Q., Xue, H., Zeng, Y., Xiao, J., Mi, J., Tang, Y., & Ling, W. (2023). Epigenetic modulation of Drp1-mediated mitochondrial fission by inhibition of S-adenosylhomocysteine hydrolase promotes vascular senescence and atherosclerosis. Redox Biology, 65, Article 102828. https:\/\/doi.org\/10.1016\/j.redox.2023.102828","journal-title":"Redox Biology"},{"key":"10189_CR92","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/CIRCULATIONAHA.118.037308","volume":"139","author":"FF Hoyer","year":"2019","unstructured":"Hoyer, F. F., & Nahrendorf, M. (2019). Uremic toxins activate macrophages: Implications for atherosclerosis in chronic kidney disease. Circulation, 139, 97\u2013100. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037308","journal-title":"Circulation"},{"key":"10189_CR93","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/ATVBAHA.120.315452","volume":"41","author":"C Drummer","year":"2021","unstructured":"Drummer, C., Saaoud, F., Shao, Y., Sun, Y., Xu, K., Lu, Y., Ni, D., Atar, D., Jiang, X., Wang, H., & Yang, X. (2021). Trained immunity and reactivity of macrophages and endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 41, 1032\u20131046. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315452","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10189_CR94","doi-asserted-by":"publisher","unstructured":"Campillo, S., Bohorquez, L., Guti\u00e9rrez-Calabr\u00e9s, E., Garc\u00eda-Ayuso, D., Miguel, V., Griera, M., Calle, Y., de Frutos, S., Rodr\u00edguez-Puyol, M., Rodr\u00edguez-Puyol, D., & Calleros, L. (2022). Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation. Experimental and Molecular Medicine, 54, 226\u2013238. https:\/\/doi.org\/10.1038\/s12276-022-00738-8","DOI":"10.1038\/s12276-022-00738-8"},{"key":"10189_CR95","doi-asserted-by":"publisher","unstructured":"Bekkering, S., van den Munckhof, I., Nielen, T., Lamfers, E., Dinarello, C., Rutten, J., de Graaf, J., Joosten, L. A. B., Netea, M. G., Gomes, M. E. R., & Riksen, N. P. (2016). Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Atherosclerosis, 254, 228\u2013236. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.019","DOI":"10.1016\/j.atherosclerosis.2016.10.019"},{"key":"10189_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.335","author":"RS Dwivedi","year":"2011","unstructured":"Dwivedi, R. S., Herman, J. G., McCaffrey, T., & Raj, D. S. (2011). Beyond genetics: Epigenetic code in chronic kidney disease. Kidney International. https:\/\/doi.org\/10.1038\/ki.2010.335","journal-title":"Kidney International"},{"key":"10189_CR97","doi-asserted-by":"publisher","unstructured":"Zawada, A. M., Schneider, J. S., Michel, A. I., Rogacev, K. S., Hummel, B., Krezdorn, N., M\u00fcller, S., Rotter, B., Winter, P., Obeid, R., Geisel, J., Fliser, D., & Heine, G. H. (2016). DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation. Epigenetics, 11, 259\u2013272. https:\/\/doi.org\/10.1080\/15592294.2016.1158363","DOI":"10.1080\/15592294.2016.1158363"},{"key":"10189_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10030124","volume":"10","author":"T Wakamatsu","year":"2018","unstructured":"Wakamatsu, T., Yamamoto, S., Ito, T., Sato, Y., Matsuo, K., Takahashi, Y., Kaneko, Y., Goto, S., Kazama, J. J., Gejyo, F., & Narita, I. (2018). Indoxyl sulfate promotes macrophage IL-1\u03b2 production by activating aryl hydrocarbon receptor\/NF-\u03ba\/MAPK cascades, but the NLRP3 inflammasome was not activated. Toxins, 10, Article 124. https:\/\/doi.org\/10.3390\/toxins10030124","journal-title":"Toxins"},{"key":"10189_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/biom14010029","volume":"14","author":"F Macr\u00ec","year":"2023","unstructured":"Macr\u00ec, F., Vigorito, I., Castiglione, S., Faggiano, S., Casaburo, M., Fanotti, N., Piacentini, L., Vigetti, D., Vinci, M. C., & Raucci, A. (2023). High phosphate-induced JAK-STAT signalling sustains vascular smooth muscle cell inflammation and limits calcification. Biomolecules, 14, Article 29. https:\/\/doi.org\/10.3390\/biom14010029","journal-title":"Biomolecules"},{"key":"10189_CR100","doi-asserted-by":"publisher","first-page":"1619018","DOI":"10.3389\/fcvm.2025.1619018","volume":"12","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y., Li, H., & Guo, Y. (2025). Interleukin family in vascular calcification: Molecular mechanisms and therapeutic perspectives. Front Cardiovasc Med, 12, 1619018. https:\/\/doi.org\/10.3389\/fcvm.2025.1619018","journal-title":"Front Cardiovasc Med"},{"key":"10189_CR101","doi-asserted-by":"publisher","first-page":"823450","DOI":"10.3389\/fcell.2022.823450","volume":"10","author":"L Yaker","year":"2022","unstructured":"Yaker, L., Tebani, A., Lesueur, C., Dias, C., Jung, V., Bekri, S., Guerrera, I. C., Kamel, S., Ausseil, J., & Boullier, A. (2022). Extracellular Vesicles From LPS-Treated Macrophages Aggravate Smooth Muscle Cell Calcification by Propagating Inflammation and Oxidative Stress. Front Cell Dev Biol, 10, 823450. https:\/\/doi.org\/10.3389\/fcell.2022.823450","journal-title":"Front Cell Dev Biol"},{"key":"10189_CR102","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1161\/CIRCRESAHA.113.301036","volume":"113","author":"SEP New","year":"2013","unstructured":"New, S. E. P., Goettsch, C., Aikawa, M., Marchini, J. F., Shibasaki, M., Yabusaki, K., Libby, P., Shanahan, C. M., Croce, K., & Aikawa, E. (2013). Macrophage-derived matrix vesicles: An alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res, 113, 72\u201377. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.301036","journal-title":"Circ Res"},{"key":"10189_CR103","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","volume":"94","author":"K Durlacher-Betzer","year":"2018","unstructured":"Durlacher-Betzer, K., Hassan, A., Levi, R., Axelrod, J., Silver, J., & Naveh-Many, T. (2018). Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney International, 94, 315\u2013325. https:\/\/doi.org\/10.1016\/j.kint.2018.02.026","journal-title":"Kidney International"},{"key":"10189_CR104","doi-asserted-by":"publisher","first-page":"24018","DOI":"10.1021\/acsomega.4c08038","volume":"10","author":"CY Sun","year":"2025","unstructured":"Sun, C. Y., Lin, Y. T., Huang, Y. T., Cheng, H. C., Chou, W. C., Chang, Y. T., Ling, T. C., Hsieh, P. L., & Tsai, K. L. (2025). Klotho Suppresses Indoxyl Sulfate-Mediated Apoptosis in Human Kidney Proximal Tubular (HK-2) Cells through Modulating the AKT\/Nrf2 Mechanism. ACS Omega, 10, 24018\u201324029. https:\/\/doi.org\/10.1021\/acsomega.4c08038","journal-title":"ACS Omega"},{"key":"10189_CR105","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1681\/ASN.2015111266","volume":"28","author":"JM Hum","year":"2017","unstructured":"Hum, J. M., O\u2019Bryan, L. M., Tatiparthi, A. K., Cass, T. A., Clinkenbeard, E. L., Cramer, M. S., Bhaskaran, M., Johnson, R. L., Wilson, J. M., Smith, R. C., & White, K. E. (2017). Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho. Journal Of The American Society Of Nephrology, 28, 1162\u20131174. https:\/\/doi.org\/10.1681\/ASN.2015111266","journal-title":"Journal Of The American Society Of Nephrology"},{"key":"10189_CR106","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41569-023-00903-0","volume":"21","author":"D Edmonston","year":"2024","unstructured":"Edmonston, D., Grabner, A., & Wolf, M. (2024). FGF23 and klotho at the intersection of kidney and cardiovascular disease. Nature Reviews. Cardiology, 21, 11\u201324. https:\/\/doi.org\/10.1038\/s41569-023-00903-0","journal-title":"Nature Reviews. Cardiology"},{"key":"10189_CR107","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ki.2009.24","volume":"75","author":"M Ohnishi","year":"2009","unstructured":"Ohnishi, M., Nakatani, T., Lanske, B., & Razzaque, M. S. (2009). Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney International, 75, 1166\u20131172. https:\/\/doi.org\/10.1038\/ki.2009.24","journal-title":"Kidney International"},{"key":"10189_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081808","volume":"9","author":"AK Meyers","year":"2020","unstructured":"Meyers, A. K., & Zhu, X. (2020). The NLRP3 inflammasome: Metabolic regulation and contribution to inflammaging. Cells, 9, Article 1808. https:\/\/doi.org\/10.3390\/cells9081808","journal-title":"Cells"},{"key":"10189_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.936167","volume":"13","author":"A Marrocco","year":"2022","unstructured":"Marrocco, A., & Ortiz, L. A. (2022). Role of metabolic reprogramming in pro-inflammatory cytokine secretion from LPS or silica-activated macrophages. Frontiers in Immunology, 13, Article 936167. https:\/\/doi.org\/10.3389\/fimmu.2022.936167","journal-title":"Frontiers in Immunology"},{"key":"10189_CR110","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2017.12.007","volume":"115","author":"Y Dautova","year":"2018","unstructured":"Dautova, Y., Kapustin, A. N., Pappert, K., Epple, M., Okkenhaug, H., Cook, S. J., Shanahan, C. M., Bootman, M. D., & Proudfoot, D. (2018). Calcium phosphate particles stimulate interleukin-1\u03b2 release from human vascular smooth muscle cells: A role for spleen tyrosine kinase and exosome release. Journal of Molecular and Cellular Cardiology, 115, 82\u201393. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.12.007","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10189_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113803","volume":"432","author":"X Sun","year":"2023","unstructured":"Sun, X., Zheng, Y., Xie, L., Zhou, Y., Liu, R., Ma, Y., Zhao, M., & Liu, Y. (2023). Autophagy reduces aortic calcification in diabetic mice by reducing matrix vesicle body-mediated IL-1\u03b2 release. Experimental Cell Research, 432, Article 113803. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113803","journal-title":"Experimental Cell Research"},{"key":"10189_CR112","doi-asserted-by":"publisher","first-page":"1662989","DOI":"10.3389\/fcvm.2025.1662989","volume":"12","author":"Y Lin","year":"2025","unstructured":"Lin, Y., Zhang, H., Jiang, Y., & Tian, W. (2025). Oxidative stress and its related epigenetic modifications in vascular calcification: Mechanisms and advances. Front Cardiovasc Med, 12, 1662989. https:\/\/doi.org\/10.3389\/fcvm.2025.1662989","journal-title":"Front Cardiovasc Med"},{"key":"10189_CR113","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/genes16050506","volume":"16","author":"LP Kajuluri","year":"2025","unstructured":"Kajuluri, L. P., Guo, Y. Y., Lee, S., Christof, M., & Malhotra, R. (2025). Epigenetic Regulation of Human Vascular Calcification. Genes (Basel), 16, 506. https:\/\/doi.org\/10.3390\/genes16050506","journal-title":"Genes (Basel)"},{"key":"10189_CR114","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18063","volume":"12","author":"X Liang","year":"2024","unstructured":"Liang, X., Li, Y., Wang, P., & Liu, H. (2024). Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2. PeerJ, 12, Article e18063. https:\/\/doi.org\/10.7717\/peerj.18063","journal-title":"PeerJ"},{"key":"10189_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109458","volume":"66","author":"RA da Silva","year":"2020","unstructured":"da Silva, R. A., da S Feltran, G., da C Fernandes, C. J., & Zambuzzi, W. F. (2020). Osteogenic gene markers are epigenetically reprogrammed during contractile-to-calcifying vascular smooth muscle cell phenotype transition. Cellular Signalling, 66, Article 109458. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109458","journal-title":"Cellular Signalling"},{"key":"10189_CR116","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","volume":"14","author":"CJ Ferro","year":"2018","unstructured":"Ferro, C. J., Mark, P. B., Kanbay, M., Sarafidis, P., Heine, G. H., Rossignol, P., Massy, Z. A., Mallamaci, F., Valdivielso, J. M., Malyszko, J., Verhaar, M. C., Ekart, R., Vanholder, R., London, G., Ortiz, A., & Zoccali, C. (2018). Lipid management in patients with chronic kidney disease. Nature Reviews Nephrology, 14, 727\u2013749. https:\/\/doi.org\/10.1038\/s41581-018-0072-9","journal-title":"Nature Reviews Nephrology"},{"key":"10189_CR117","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1592\/phco.30.8.823","volume":"30","author":"JC Marrs","year":"2010","unstructured":"Marrs, J. C., & Saseen, J. J. (2010). Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy, 30, 823\u2013829. https:\/\/doi.org\/10.1592\/phco.30.8.823","journal-title":"Pharmacotherapy"},{"key":"10189_CR118","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","volume":"4","author":"Impact of renal function on the effects","year":"2016","unstructured":"Impact of renal function on the effects. (2016). of LDL cholesterol lowering with statin-based regimens: A meta-analysis of individual participant data from 28 randomised trials. The Lancet Diabetes & Endocrinology, 4, 829\u2013839. https:\/\/doi.org\/10.1016\/S2213-8587(16)30156-5","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10189_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10090367","volume":"10","author":"W-C Liu","year":"2018","unstructured":"Liu, W.-C., Tomino, Y., & Lu, K.-C. (2018). Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120. Toxins, 10, Article 367. https:\/\/doi.org\/10.3390\/toxins10090367","journal-title":"Toxins"},{"key":"10189_CR120","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., DiDonato, A. J., Fu, X., Hazen, J. E., Krajcik, D., DiDonato, J. A., Lusis, A. J., & Hazen, S. L. (2015). Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell, 163, 1585\u20131595. https:\/\/doi.org\/10.1016\/j.cell.2015.11.055","journal-title":"Cell"},{"key":"10189_CR121","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","volume":"24","author":"AB Roberts","year":"2018","unstructured":"Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., Barrington, W. T., Russel, M. W., Reed, J. M., Duzan, A., Lang, J. M., Fu, X., Li, L., Myers, A. J., Rachakonda, S., DiDonato, J. A., Brown, J. M., Gogonea, V., Lusis, A. J., Garcia-Garcia, J. C., & Hazen, S. L. (2018). Development of a gut microbe-targeted non-lethal therapeutic to inhibit thrombosis potential. Nature Medicine, 24, 1407\u20131417. https:\/\/doi.org\/10.1038\/s41591-018-0128-1","journal-title":"Nature Medicine"},{"key":"10189_CR122","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/MNH.0000000000000062","volume":"23","author":"SK Mallipattu","year":"2014","unstructured":"Mallipattu, S. K., & Uribarri, J. (2014). Advanced glycation end product accumulation: A new enemy to target in chronic kidney disease? Current Opinion In Nephrology And Hypertension, 23, 547\u2013554. https:\/\/doi.org\/10.1097\/MNH.0000000000000062","journal-title":"Current Opinion In Nephrology And Hypertension"},{"key":"10189_CR123","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","volume":"34","author":"S Bekkering","year":"2014","unstructured":"Bekkering, S., Quintin, J., Joosten, L. A. B., van der Meer, J. W. M., Netea, M. G., & Riksen, N. P. (2014). Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arteriosclerosis Thrombosis and Vascular Biology, 34, 1731\u20131738. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303887","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"key":"10189_CR124","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2015.09.019","volume":"243","author":"I Six","year":"2015","unstructured":"Six, I., Gross, P., R\u00e9mond, M. C., Chillon, J. M., Poirot, S., Drueke, T. B., & Massy, Z. A. (2015). Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120. Atherosclerosis, 243, 248\u2013256. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.09.019","journal-title":"Atherosclerosis"},{"key":"10189_CR125","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/ndt\/gfq759","volume":"26","author":"S Yamamoto","year":"2011","unstructured":"Yamamoto, S., Zuo, Y., Ma, J., Yancey, P. G., Hunley, T. E., Motojima, M., Fogo, A. B., Linton, M. F., Fazio, S., Ichikawa, I., & Kon, V. (2011). Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrology, Dialysis, Transplantation, 26, 2491\u20132497. https:\/\/doi.org\/10.1093\/ndt\/gfq759","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10189_CR126","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2215\/CJN.05340610","volume":"6","author":"M Yu","year":"2011","unstructured":"Yu, M., Kim, Y. J., & Kang, D.-H. (2011). Indoxyl sulfate\u2013induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clinical Journal of the American Society of Nephrology, 6, 30\u201339. https:\/\/doi.org\/10.2215\/CJN.05340610","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10189_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010531","volume":"23","author":"E Harlacher","year":"2022","unstructured":"Harlacher, E., Wollenhaupt, J., Baaten, C. C. F. M. J., & Noels, H. (2022). Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: A systematic review. International Journal of Molecular Sciences, 23, Article 531. https:\/\/doi.org\/10.3390\/ijms23010531","journal-title":"International Journal of Molecular Sciences"},{"key":"10189_CR128","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","volume":"65","author":"FD Filippis","year":"2016","unstructured":"Filippis, F. D., Pellegrini, N., Vannini, L., Jeffery, I. B., Storia, A. L., Laghi, L., Serrazanetti, D. I., Cagno, R. D., Ferrocino, I., Lazzi, C., Turroni, S., Cocolin, L., Brigidi, P., Neviani, E., Gobbetti, M., O\u2019Toole, P. W., & Ercolini, D. (2016). High-level adherence to a mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut, 65, 1812\u20131821. https:\/\/doi.org\/10.1136\/gutjnl-2015-309957","journal-title":"Gut"},{"key":"10189_CR129","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","volume":"40","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., Krauss, R. M., & Hazen, S. L. (2019). Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. European Heart Journal, 40, 583\u2013594. https:\/\/doi.org\/10.1093\/eurheartj\/ehy799","journal-title":"European Heart Journal"},{"key":"10189_CR130","doi-asserted-by":"publisher","first-page":"46616","DOI":"10.1074\/jbc.M307155200","volume":"278","author":"PA Voziyan","year":"2003","unstructured":"Voziyan, P. A., Khalifah, R. G., Thibaudeau, C., Yildiz, A., Jacob, J., Serianni, A. S., Hudson, B. G., & INHIBITS CONVERSION OF AMADORI INTERMEDIATE TO ADVANCED GLYCATION END-PRODUCTS THROUGH BINDING OF REDOX METAL IONS *. (2003). Modification of proteins in vitro by physiological levels of glucose: PYRIDOXAMINE. Journal of Biological Chemistry, 278, 46616\u201346624. https:\/\/doi.org\/10.1074\/jbc.M307155200","journal-title":"Journal of Biological Chemistry"},{"key":"10189_CR131","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1172\/JCI118397","volume":"97","author":"JL Wautier","year":"1996","unstructured":"Wautier, J. L., Zoukourian, C., Chappey, O., Wautier, M. P., Guillausseau, P. J., Cao, R., Hori, O., Stern, D., & Schmidt, A. M. (1996). Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest, 97, 238\u2013243. https:\/\/doi.org\/10.1172\/JCI118397","journal-title":"J Clin Invest"},{"key":"10189_CR132","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1172\/JCI14002","volume":"108","author":"AM Schmidt","year":"2001","unstructured":"Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001). The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest, 108, 949\u2013955. https:\/\/doi.org\/10.1172\/JCI14002","journal-title":"J Clin Invest"},{"key":"10189_CR133","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/01.ASN.0000051593.41395.B9","volume":"14","author":"J Uribarri","year":"2003","unstructured":"Uribarri, J., Peppa, M., Cai, W., Goldberg, T., Lu, M., He, C., & Vlassara, H. (2003). Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. Journal of the American Society of Nephrology, 14, 728\u2013731. https:\/\/doi.org\/10.1097\/01.ASN.0000051593.41395.B9","journal-title":"Journal of the American Society of Nephrology"},{"key":"10189_CR134","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.ki.5002250","volume":"72","author":"R Ramirez","year":"2007","unstructured":"Ramirez, R., Carracedo, J., Merino, A., Nogueras, S., Alvarez-Lara, M. A., Rodr\u00edguez, M., Martin-Malo, A., Tetta, C., & Aljama, P. (2007). Microinflammation induces endothelial damage in hemodialysis patients: The role of convective transport. Kidney International, 72, 108\u2013113. https:\/\/doi.org\/10.1038\/sj.ki.5002250","journal-title":"Kidney International"},{"key":"10189_CR135","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.4049\/jimmunol.1800747","volume":"202","author":"C Cavallari","year":"2019","unstructured":"Cavallari, C., Dellepiane, S., Fonsato, V., Medica, D., Marengo, M., Migliori, M., Quercia, A. D., Pitino, A., Formica, M., Panichi, V., Maffei, S., Biancone, L., Gatti, E., Tetta, C., Camussi, G., & Cantaluppi, V. (2019). Online hemodiafiltration inhibits inflammation-related endothelial dysfunction and vascular calcification of uremic patients modulating miR-223 expression in plasma extracellular vesicles. The Journal of Immunology, 202, 2372\u20132383. https:\/\/doi.org\/10.4049\/jimmunol.1800747","journal-title":"The Journal of Immunology"},{"key":"10189_CR136","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMoa2304820","volume":"389","author":"PJ Blankestijn","year":"2023","unstructured":"Blankestijn, P. J., Vernooij, R. W. M., Hockham, C., Strippoli, G. F. M., Canaud, B., Hegbrant, J., Barth, C., Covic, A., Cromm, K., Cucui, A., Davenport, A., Rose, M., T\u00f6r\u00f6k, M., Woodward, M., & Bots, M. L. (2023). Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. New England Journal of Medicine, 389, 700\u2013709. https:\/\/doi.org\/10.1056\/NEJMoa2304820","journal-title":"New England Journal of Medicine"},{"key":"10189_CR137","doi-asserted-by":"publisher","unstructured":"Vernooij, R. W. M., Hockham, C., Strippoli, G., Green, S., Hegbrant, J., Davenport, A., Barth, C., Canaud, B., Woodward, M., Blankestijn, P. J., Bots, M. L., CONVINCE Scientific Committee, HDF Pooling Project Investigators. (2024). Haemodiafiltration versus haemodialysis for kidney failure: An individual patient data meta-analysis of randomised controlled trials. Lancet Article S0140-6736(24)01859\u20132. https:\/\/doi.org\/10.1016\/S0140-6736(24)01859-2","DOI":"10.1016\/S0140-6736(24)01859-2"},{"key":"10189_CR138","doi-asserted-by":"publisher","unstructured":"Keating, S. T., Groh, L., Thiem, K., Bekkering, S., Li, Y., Matzaraki, V., van der Heijden, C. D. C. C., van Puffelen, J. H., Lachmandas, E., Jansen, T., Oosting, M., de Bree, L. C. J., Koeken, V. A. C. M., Moorlag, S. J. C. F. M., Mourits, V. P., van Diepen, J., Strienstra, R., Novakovic, B., Stunnenberg, H. G., \u2026 Riksen, N. P. (2020). Rewiring of glucose metabolism defines trained immunity induced by oxidized low-density lipoprotein. Journal of Molecular Medicine (Berlin, Germany), 98, 819\u2013831. https:\/\/doi.org\/10.1007\/s00109-020-01915-w","DOI":"10.1007\/s00109-020-01915-w"},{"key":"10189_CR139","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5483\/BMBRep.2021.54.3.136","volume":"54","author":"EJ Song","year":"2021","unstructured":"Song, E. J., Ahn, S., Min, S.-K., Ha, J., & Oh, G. T. (2021). Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease. BMB Reports, 54, 170. https:\/\/doi.org\/10.5483\/BMBRep.2021.54.3.136","journal-title":"BMB Reports"},{"key":"10189_CR140","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/01.CIR.0000112572.57794.22","volume":"109","author":"DR Holmes","year":"2004","unstructured":"Holmes, D. R., Leon, M. B., Moses, J. W., Popma, J. J., Cutlip, D., Fitzgerald, P. J., Brown, C., Fischell, T., Wong, S. C., Midei, M., Snead, D., & Kuntz, R. E. (2004). Analysis of 1-year clinical outcomes in the SIRIUS trial: A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation, 109, 634\u2013640. https:\/\/doi.org\/10.1161\/01.CIR.0000112572.57794.22","journal-title":"Circulation"},{"key":"10189_CR141","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O\u2019Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., Jaeger, J. L., & Kuntz, R. E. (2003). Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. New England Journal of Medicine, 349, 1315\u20131323. https:\/\/doi.org\/10.1056\/NEJMoa035071","journal-title":"New England Journal of Medicine"},{"key":"10189_CR142","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202500802R","volume":"39","author":"A Scarpa","year":"2025","unstructured":"Scarpa, A., Jung, Y., Hamid, A., Matzaraki, V., More, T., Heinz, A., Groh, L., Bekkering, S., Hiller, K., Joosten, L. A. B., Netea, M. G., Placek, K., & Riksen, N. P. (2025). Trained immunity induced by oxidized low-density lipoprotein is dependent on glutaminolysis. FASEB Journal, 39, Article e70774. https:\/\/doi.org\/10.1096\/fj.202500802R","journal-title":"FASEB Journal"},{"key":"10189_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104536","volume":"10","author":"MA Gouda","year":"2025","unstructured":"Gouda, M. A., Voss, M. H., Tawbi, H., Gordon, M., Tykodi, S. S., Lam, E. T., Vaishampayan, U., Tannir, N. M., Chaves, J., Nikolinakos, P., Fan, A., Lee, R., McDermott, D., Shapiro, G. I., Gandhi, L., Bhatia, S., Katragadda, V., & Meric-Bernstam, F. (2025). A phase I\/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer. ESMO Open, 10, Article 104536. https:\/\/doi.org\/10.1016\/j.esmoop.2025.104536","journal-title":"ESMO Open"},{"key":"10189_CR144","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","volume":"34","author":"S Bekkering","year":"2014","unstructured":"Bekkering, S., Quintin, J., Joosten, L. A. B., van der Meer, J. W. M., Netea, M. G., & Riksen, N. P. (2014). Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arteriosclerosis Thrombosis and Vascular Biology, 34, 1731\u20131738. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303887","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"key":"10189_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00943-0","volume":"12","author":"S Wasiak","year":"2020","unstructured":"Wasiak, S., Dzobo, K. E., Rakai, B. D., Kaiser, Y., Versloot, M., Bahjat, M., Stotz, S. C., Fu, L., Sweeney, M., Johansson, J. O., Wong, N. C. W., Stroes, E. S. G., Kroon, J., & Kulikowski, E. (2020). BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes. Clinical Epigenetics, 12, Article 166. https:\/\/doi.org\/10.1186\/s13148-020-00943-0","journal-title":"Clinical Epigenetics"},{"key":"10189_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0696-z","volume":"11","author":"LM Tsujikawa","year":"2019","unstructured":"Tsujikawa, L. M., Fu, L., Das, S., Halliday, C., Rakai, B. D., Stotz, S. C., Sarsons, C. D., Gilham, D., Daze, E., Wasiak, S., Studer, D., Rinker, K. D., Sweeney, M., Johansson, J. O., Wong, N. C. W., & Kulikowski, E. (2019). Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism. Clinical Epigenetics, 11, Article 102. https:\/\/doi.org\/10.1186\/s13148-019-0696-z","journal-title":"Clinical Epigenetics"},{"key":"10189_CR147","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2215\/CJN.16751020","volume":"16","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh, K., Schwartz, G. G., Nicholls, S. J., Buhr, K. A., Ginsberg, H. N., Johansson, J. O., Kulikowski, E., Lebioda, K., Toth, P. P., Wong, N., Sweeney, M., & Ray, K. K. (2021). Effect of apabetalone on cardiovascular events in diabetes, CKD, and recent acute coronary syndrome. Clinical Journal of the American Society of Nephrology, 16, 705\u2013716. https:\/\/doi.org\/10.2215\/CJN.16751020","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10189_CR148","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1210\/en.2014-1595","volume":"155","author":"Q Cao","year":"2014","unstructured":"Cao, Q., Wang, X., Jia, L., Mondal, A. K., Diallo, A., Hawkins, G. A., Das, S. K., Parks, J. S., Yu, L., Shi, H., Shi, H., & Xue, B. (2014). Inhibiting DNA methylation by 5-aza-2\u2032-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology, 155, 4925\u20134938. https:\/\/doi.org\/10.1210\/en.2014-1595","journal-title":"Endocrinology"},{"key":"10189_CR149","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1158\/1078-0432.CCR-21-3729","volume":"28","author":"MR Baer","year":"2022","unstructured":"Baer, M. R., Kogan, A. A., Bentzen, S. M., Mi, T., Lapidus, R. G., Duong, V. H., Emadi, A., Niyongere, S., O\u2019Connell, C. L., Youngblood, B. A., Baylin, S. B., & Rassool, F. V. (2022). Phase I clinical trial of DNA methyltransferase inhibitor decitabine and PARP inhibitor talazoparib combination therapy in relapsed\/refractory acute myeloid leukemia. Clinical Cancer Research, 28, 1313\u20131322. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3729","journal-title":"Clinical Cancer Research"},{"key":"10189_CR150","doi-asserted-by":"publisher","unstructured":"van Leent, M. M. T., Beldman, T. J., Toner, Y. C., Lameijer, M. A., Rother, N., Bekkering, S., Teunissen, A. J. P., Zhou, X., van der Meel, R., Malkus, J., Nauta, S. A., Klein, E. D., Fay, F., Sanchez-Gaytan, B. L., P\u00e9rez-Medina, C., Kluza, E., Ye, Y.-X., Wojtkiewicz, G., Fisher, E. A., \u2026 Duivenvoorden, R. (2021). Prosaposin mediates inflammation in atherosclerosis. Science Translational Medicine, 13, Article eabe1433. https:\/\/doi.org\/10.1126\/scitranslmed.abe1433","DOI":"10.1126\/scitranslmed.abe1433"},{"key":"10189_CR151","doi-asserted-by":"publisher","first-page":"eabe7853","DOI":"10.1126\/sciadv.abe7853","volume":"7","author":"MMT van Leent","year":"2021","unstructured":"van Leent, M. M. T., Meerwaldt, A. E., Berchouchi, A., Toner, Y. C., Burnett, M. E., Klein, E. D., Verschuur, A. V. D., Nauta, S. A., Munitz, J., Pr\u00e9vot, G., van Leeuwen, E. M., Ordikhani, F., Mourits, V. P., Calcagno, C., Robson, P. M., Soultanidis, G., Reiner, T., Joosten, R. R. M., Friedrich, H., Madsen, J. C., Kluza, E., van der Meel, R., Joosten, L. A. B., Netea, M. G., Ochando, J., Fayad, Z. A., P\u00e9rez-Medina, C., Mulder, W. J. M., & Teunissen, A. J. P. (2021). A modular approach toward producing nanotherapeutics targeting the innate immune system. Science Advances, 7, eabe7853. https:\/\/doi.org\/10.1126\/sciadv.abe7853","journal-title":"Science Advances"},{"key":"10189_CR152","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41569-023-00894-y","volume":"20","author":"NP Riksen","year":"2023","unstructured":"Riksen, N. P., Bekkering, S., Mulder, W. J. M., & Netea, M. G. (2023). Trained immunity in atherosclerotic cardiovascular disease. Nature Reviews Cardiology, 20, 799\u2013811. https:\/\/doi.org\/10.1038\/s41569-023-00894-y","journal-title":"Nature Reviews Cardiology"},{"key":"10189_CR153","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., Kastelein, J. J. P., Cornel, J. H., Pais, P., Pella, D., Genest, J., Cifkova, R., Lorenzatti, A., Forster, T., Kobalava, Z., Vida-Simiti, L., Flather, M., Shimokawa, H., Ogawa, H., Dellborg, M., Rossi, P. R. F., Troquay, R. P. T., Libby, P., & Glynn, R. J. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine, 377, 1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"New England Journal of Medicine"},{"key":"10189_CR154","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","volume":"4","author":"V Faure","year":"2006","unstructured":"Faure, V., Dou, L., Sabatier, F., Cerini, C., Sampol, J., Berland, Y., Brunet, P., & Dignat-George, F. (2006). Elevation of circulating endothelial microparticles in patients with chronic renal failure. Journal Of Thrombosis And Haemostasis, 4, 566\u2013573. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01780.x","journal-title":"Journal Of Thrombosis And Haemostasis"},{"key":"10189_CR155","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.toxlet.2021.04.019","volume":"347","author":"G Favretto","year":"2021","unstructured":"Favretto, G., da Cunha, R. S., Santos, A. F., Leitolis, A., Schiefer, E. M., Greg\u00f3rio, P. C., Franco, C. R. C., Massy, Z. A., Dalboni, M. A., & Stinghen, A. E. M. (2021). Uremic endothelial-derived extracellular vesicles: Mechanisms of formation and their role in cell adhesion, cell migration, inflammation, and oxidative stress. Toxicology Letters, 347, 12\u201322. https:\/\/doi.org\/10.1016\/j.toxlet.2021.04.019","journal-title":"Toxicology Letters"},{"key":"10189_CR156","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1681\/ASN.2017050523","volume":"29","author":"LL Lv","year":"2018","unstructured":"Lv, L. L., Feng, Y., Wen, Y., Wu, W. J., Ni, H. F., Li, Z. L., Zhou, L. T., Wang, B., Zhang, J. D., Crowley, S. D., & Liu, B. C. (2018). Exosomal CCL2 from tubular epithelial cells is critical for albumin-induced tubulointerstitial inflammation. Journal Of The American Society Of Nephrology, 29, 919\u2013935. https:\/\/doi.org\/10.1681\/ASN.2017050523","journal-title":"Journal Of The American Society Of Nephrology"},{"key":"10189_CR157","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.kint.2018.09.013","volume":"95","author":"ZL Li","year":"2019","unstructured":"Li, Z. L., Lv, L. L., Tang, T. T., Wang, B., Feng, Y., Zhou, L. T., Cao, J. Y., Tang, R. N., Wu, M., Liu, H., Crowley, S. D., & Liu, B. C. (2019). HIF-1\u03b1 inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation. Kidney International, 95, 388\u2013404. https:\/\/doi.org\/10.1016\/j.kint.2018.09.013","journal-title":"Kidney International"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10189-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:46:51Z","timestamp":1792144011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10189-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":157,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10189"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10189-6","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"122"}}